Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International Medical Systems. MNTA CEO Craig Wheeler notes the opinion is a setback for the company and has "potentially wide ranging implications for all patent holders." Shares +3.6% AH.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (Dec 8, 2014)
at MarketWatch.com (Oct 29, 2014)
at MarketWatch.com (Oct 20, 2014)
at MarketWatch.com (Aug 21, 2014)
at MarketWatch.com (Aug 5, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs